Global Elbow Lesion Treatment Market, Treatment Surgical, Non-Surgical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Elbow Lesion Treatment Market Analysis and Size
Increased occurrences of sport-related bone diseases and increased advancement in the innovative treatment for joint & bone-related conditions will boost the global elbow lesion treatment market. Elbow disorders can be diagnosed by physical examination, x-rays, magnetic resonance imaging, electromyography, computerized tomography scan, and biopsy of bursa fluid. Several new advancements in minimally invasive surgeries by medical device manufacturers are majorly focusing on evolving economies due to large patient base and growing demand for bone-related surgeries.
Data Bridge Market Research analyses a growth rate in the global elbow lesion treatment market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Elbow Lesion Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Treatment (Surgical, Non-Surgical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Zimmer Biomet (U.S.), Stryker Corporation (U.S.), ExaTech Inc. (U.S.), Arthrex, Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Medacta International (Switzerland)
|
|
Market Opportunities
|
|
Market Definition
Elbow lesions are injuries that disrupt the subjacent bone and cartilage, majorly affecting the capitellum. It is the major problems in adolescent overhead athletes and the causes are likely multifactorial secondary to repetitive stresses, biomechanical mismatch, and a tenuous vascular supply of the capitellum. Different types of elbow disorders include lateral epicondylitis, olecranon bursitis, osteoarthritis, medial epicondylitis, the dislocation or fracture of the elbow, ligaments strains and sprains, and osteochondritis dissecans.
Global Elbow Lesion Treatment Market Dynamics
Drivers
- Increase in Bone Injury Cases
As per the National Institute for Health and Care Excellence (NICE) records, tennis elbow was incident in 1%-3% of U.K. population in 2012. It has been witnessed that people above 60 years are more affected with elbow pain. Thus, rapidly growing elderly population and increasing incidence of arm fracture because of accidents are projected to boost the elbow lesion treatment market in the near future. This boosts the growth of the market.
- Growing Advanced Techniques
Increasing advanced techniques that are coming up with each passing decade is boosting the growth of the market. For instance, platelet-rich plasma (PRP) is favored for tennis elbow treatment. The procedure involves taking a blood sample from the patient, which is then further treated to increase the number of platelets than other cells in the sample. Physical therapies such as muscle stimulation and ice massage are used to speed up the healing process. Thus, these techniques boost the growth of the market.
Opportunities
- Rising Incidence of Sports Injuries
Growing number of sports events and competitions in the U.S, good medical facilities, and favorable reimbursement policies are driving the elbow lesion market growth. Elbow injuries are considered to be an anticipated consequence of throwing sports. As per the study published in Orthopaedic Journal of Sports Medicine in 2013, around 30% of baseball players will have elbow pain each year, and approximately 60% of players with elbow pain will show radiographic abnormalities. The elbow lesion market in evolving markets such as India, China, Russia, and Brazil is increasing because of the increase in number of sports injuries in these regions, use of advanced technology in diagnosis, and improving medical facilities provided by government and private companies
- Rising R&D activities
Increasing R&D activities helping in creating more opportunities for the market growth. Major institutes focus on researching elbow lesion and related conditions. For instance, in September 2019, a research was conducted by Lutheran University of Brazil that was published in the Journal of Shoulder and Elbow Surgery and it was found that Iontophoresis proved to be an effective technique in decreasing pain and improving strength and function in individuals with tennis elbow.
Restraints/Challenges
- Limited Studies and Surveys
There are very limited studies and surveys that is hampering the growth of the market. Only a minimal amount of data are available with respect to the studies. A few studies mainly focused on groups from a single hospital wherein only a limited number of patients are observed. Thus, this hampers the growth of the market.
- High Cost
The huge expenditure associated with elbow lesion medications hamper the market growth. This disease involves treatment with different antibiotics, surgery, which demands huge expenditure. This acts as a major hindrance for the market.
This global elbow lesion treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global elbow lesion treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Elbow Lesion Treatment Market
COVID-19 has left a major global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period. It has been observed that COVID-19 can induce a systemic inflammatory response, and its clinical appearances are different.
In the post-pandemic era, the market is expected to rise because of the availability of varied treatment options, such as anti-inflammatory therapy, that may benefit patients. Other than that, glucocorticoids, antagonists are also helpful.
Recent Developments
- In January 2019, researchers from Hospital Universitario Virgen del Rocío, Spain, found that ultrasound-guided treatment with botulinum toxin in patients with lateral epicondylitis may be a practical treatment approach in the suitable patient population.
Global Elbow Lesion Treatment Market Scope
The global elbow lesion treatment market is segmented on the basis of treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Surgical
- Non-Surgical
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Elbow Lesion Treatment Market Regional Analysis/Insights
The global elbow lesion treatment market is analyzed and market size insights and trends are provided by treatment, distribution channel and end-user as referenced above.
The major countries covered in the global elbow lesion treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing positive growth for global elbow lesion treatment market throughout the forecasted period due to the region's increased incidence of sports injuries and well-established health care infrastructure.
Asia-Pacific dominates the market due to the increased prevalence of bone & joint related diseases and increased advancement in the technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Elbow Lesion Treatment Market Share Analysis
The global elbow lesion treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global elbow lesion treatment market.
Key players operating in the global elbow lesion treatment market include:
- Zimmer Biomet (U.S.)
- Stryker Corporation (U.S.)
- ExaTech Inc. (U.S.)
- Arthrex, Inc. (U.S.)
- Takeda Pharmaceutical Company Limited (Japan)
- Medacta International (Switzerland)
SKU-